The Korean journal of internal medicine

  • 제32권6호
  • /
  • Pages.998-1001
  • /
  • 2017
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Utility and drawbacks of [18]F-fluorodeoxyglucose positron emission tomography in the evaluation of adult-onset Still's disease

  • Yoo, Dae Hyun (Division of Rheumatology, Department of Internal Medicine, Hanyang University College of Medicine)
  • 투고 : 2017.10.09
  • 심사 : 2017.10.13
  • 발행 : 2017.11.01
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Kadavath S, Efthimiou P. Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options. Ann Med 2015;47:6-14. https://doi.org/10.3109/07853890.2014.971052
  2. Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-430.
  3. Pouchot J, Sampalis JS, Beaudet F, et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 1991;70:118-136. https://doi.org/10.1097/00005792-199103000-00004
  4. Yoo DH. Treatment of adult-onset still's disease: up to date. Expert Rev Clin Immunol 2017;13:849-866. https://doi.org/10.1080/1744666X.2017.1332994
  5. Jung KH, Kim JJ, Lee JS, et al. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease. Scand J Rheumatol 2014;43:162-169. https://doi.org/10.3109/03009742.2013.824023
  6. Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 2008;8:705-713. https://doi.org/10.1038/nrc2468
  7. Yamashita H, Kubota K, Mimori A. Clinical value of whole-body PET/CT in patients with active rheumatic diseases. Arthritis Res Ther 2014;16:423. https://doi.org/10.1186/s13075-014-0423-2
  8. Funauchi M, Ikoma S, Kishimoto K, et al. A case of adult onset Still's disease showing marked accumulation in the liver and spleen, on positron emission tomography-CT images. Rheumatol Int 2008;28:1061-1064. https://doi.org/10.1007/s00296-008-0562-3
  9. Cai L, Chen Y, Huang Z. Elevated FDG activity in lymph nodes as well as the spleen and liver in a patient with adult-onset still disease. Clin Nucl Med 2012;37:1009-1010. https://doi.org/10.1097/RLU.0b013e31826386d2
  10. Choe JY, Chung DS, Park SH, Kwon HH, Kim SK. Clinical significance of (1)(8)F-fluoro-dexoxyglucose positron emission tomography in patients with adult-onset Still's disease: report of two cases and review of literatures. Rheumatol Int 2010;30:1673-1676. https://doi.org/10.1007/s00296-009-1137-7
  11. Yamashita H, Kubota K, Takahashi Y, et al. Clinical value of (1)(8)F-fluoro-dexoxyglucose positron emission tomography/ computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature. Mod Rheumatol 2014;24:645-650. https://doi.org/10.3109/14397595.2013.850998
  12. Jiang L, Xiu Y, Gu T, Dong C, Wu B, Shi H. Imaging characteristics of adult onset Still's disease demonstrated with 18F-FDG PET/CT. Mol Med Rep 2017;16:3680-3686. https://doi.org/10.3892/mmr.2017.7022
  13. Dong MJ, Wang CQ, Zhao K, et al. 18F-FDG PET/CT in patients with adult-onset Still's disease. Clin Rheumatol 2015;34:2047-2056. https://doi.org/10.1007/s10067-015-2901-6
  14. An YS, Suh CH, Jung JY, Cho H, Kim HA. The role of 18F-fluorodeoxyglucose positron emission tomography in the assessment of disease activity of adult-onset Still's disease. Korean J Intern Med 2017;32:1082-1089. https://doi.org/10.3904/kjim.2015.322
  15. Priori R, Barone F, Alessandri C, et al. Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis. Rheumatology (Oxford) 2011;50:776-780. https://doi.org/10.1093/rheumatology/keq397